Takeshi Soda
Papers
3
Total Citations
16
H-Index
2
About
Takeshi Soda is a leading urological surgeon whose research focuses on optimizing outcomes in robot-assisted radical prostatectomy (RARP), particularly for prostate cancer patients. His work centers on three key areas: the impact of antiplatelet medications, the effects of aging, and the role of nerve-sparing techniques on post-surgical complications and quality of life. In his 2024 study on thienopyridine-class antiplatelets (ticlopidine, clopidogrel, prasugrel), Soda demonstrated that these agents significantly increase bleeding risks during RARP, providing critical guidance for perioperative management in cardiac patients. His parallel 2024 investigation into aging revealed that older patients face higher complication rates, informing risk stratification and preoperative counseling. Additionally, his 2023 analysis of baseline factors and nerve-sparing procedures showed that preserving neurovascular bundles improves lower urinary tract symptoms post-surgery. With over 16 citations across his most impactful papers, Soda’s work has directly enhanced surgical safety and patient-centered outcomes in robotic urology. His findings are essential reading for urologists and researchers seeking to refine RARP protocols, balance oncologic control with functional preservation, and manage complex patient populations.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3